rs7142143
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002863.5(PYGL):c.345+923A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0266 in 151,264 control chromosomes in the GnomAD database, including 171 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.027 ( 171 hom., cov: 32)
Consequence
PYGL
NM_002863.5 intron
NM_002863.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0530
Publications
12 publications found
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
- glycogen storage disease VIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0907 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PYGL | ENST00000216392.8 | c.345+923A>G | intron_variant | Intron 2 of 19 | 1 | NM_002863.5 | ENSP00000216392.7 | |||
| PYGL | ENST00000532462.5 | c.345+923A>G | intron_variant | Intron 2 of 19 | 1 | ENSP00000431657.1 | ||||
| PYGL | ENST00000530336.2 | n.412+923A>G | intron_variant | Intron 2 of 4 | 1 | |||||
| PYGL | ENST00000544180.6 | c.244-1628A>G | intron_variant | Intron 1 of 18 | 2 | ENSP00000443787.1 |
Frequencies
GnomAD3 genomes AF: 0.0265 AC: 4012AN: 151170Hom.: 170 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4012
AN:
151170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0266 AC: 4026AN: 151264Hom.: 171 Cov.: 32 AF XY: 0.0259 AC XY: 1912AN XY: 73788 show subpopulations
GnomAD4 genome
AF:
AC:
4026
AN:
151264
Hom.:
Cov.:
32
AF XY:
AC XY:
1912
AN XY:
73788
show subpopulations
African (AFR)
AF:
AC:
3836
AN:
41180
American (AMR)
AF:
AC:
131
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5124
South Asian (SAS)
AF:
AC:
1
AN:
4784
European-Finnish (FIN)
AF:
AC:
0
AN:
10326
Middle Eastern (MID)
AF:
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
AC:
18
AN:
67880
Other (OTH)
AF:
AC:
40
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
196
392
589
785
981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.